 | • レポートコード：MRC2Q12-18040 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、経口ワクチンアジュバントのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 経口ワクチンアジュバントのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 経口ワクチンアジュバントの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 経口ワクチンアジュバントのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの経口ワクチンアジュバントの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の経口ワクチンアジュバントの売上および2028年までの予測に焦点を当てています。 経口ワクチンアジュバントのグローバル主要企業には、SEPPIC、SDA BIO、Croda International、SPI Pharma、Phibro Animal Health Corporation、Tj Kaiwei、Novavax、Zhuoyue、Aphios、GSK、CSL、Brenntag Biosector、SEPPIC、SPI Pharma、Novavax、Avanti Polar Lipids、Aphiosなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 経口ワクチンアジュバント市場は、タイプとアプリケーションによって区分されます。世界の経口ワクチンアジュバント市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 動物用ワクチンアジュバント、人間用ワクチンアジュバント 【アプリケーション別セグメント】 研究用、商業用 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 経口ワクチンアジュバント製品概要 - タイプ別市場（動物用ワクチンアジュバント、人間用ワクチンアジュバント） - アプリケーション別市場（研究用、商業用） - 調査の目的 ・エグゼクティブサマリー - 世界の経口ワクチンアジュバント販売量予測2017-2028 - 世界の経口ワクチンアジュバント売上予測2017-2028 - 経口ワクチンアジュバントの地域別販売量 - 経口ワクチンアジュバントの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別経口ワクチンアジュバント販売量 - 主要メーカー別経口ワクチンアジュバント売上 - 主要メーカー別経口ワクチンアジュバント価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（動物用ワクチンアジュバント、人間用ワクチンアジュバント） - 経口ワクチンアジュバントのタイプ別販売量 - 経口ワクチンアジュバントのタイプ別売上 - 経口ワクチンアジュバントのタイプ別価格 ・アプリケーション別市場規模（研究用、商業用） - 経口ワクチンアジュバントのアプリケーション別販売量 - 経口ワクチンアジュバントのアプリケーション別売上 - 経口ワクチンアジュバントのアプリケーション別価格 ・北米市場 - 北米の経口ワクチンアジュバント市場規模（タイプ別、アプリケーション別） - 主要国別の経口ワクチンアジュバント市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの経口ワクチンアジュバント市場規模（タイプ別、アプリケーション別） - 主要国別の経口ワクチンアジュバント市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の経口ワクチンアジュバント市場規模（タイプ別、アプリケーション別） - 主要国別の経口ワクチンアジュバント市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の経口ワクチンアジュバント市場規模（タイプ別、アプリケーション別） - 主要国別の経口ワクチンアジュバント市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの経口ワクチンアジュバント市場規模（タイプ別、アプリケーション別） - 主要国別の経口ワクチンアジュバント市場規模（トルコ、サウジアラビア） ・企業情報 SEPPIC、SDA BIO、Croda International、SPI Pharma、Phibro Animal Health Corporation、Tj Kaiwei、Novavax、Zhuoyue、Aphios、GSK、CSL、Brenntag Biosector、SEPPIC、SPI Pharma、Novavax、Avanti Polar Lipids、Aphios ・産業チェーン及び販売チャネル分析 - 経口ワクチンアジュバントの産業チェーン分析 - 経口ワクチンアジュバントの原材料 - 経口ワクチンアジュバントの生産プロセス - 経口ワクチンアジュバントの販売及びマーケティング - 経口ワクチンアジュバントの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 経口ワクチンアジュバントの産業動向 - 経口ワクチンアジュバントのマーケットドライバー - 経口ワクチンアジュバントの課題 - 経口ワクチンアジュバントの阻害要因 ・主な調査結果 |
Vaccine adjuvants (Adjuvant) are a class of substances that can non-specifically change or enhance the body’s specific immune response to antigens and play an auxiliary role. Adjuvants can induce the body to produce a long-term and efficient specific immune response, improve the body’s protective ability, and at the same time reduce the dosage of immune substances and reduce the production cost of vaccines.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Oral Vaccine Adjuvants is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Oral Vaccine Adjuvants is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Oral Vaccine Adjuvants is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Oral Vaccine Adjuvants include SEPPIC, SDA BIO, Croda International, SPI Pharma, Phibro Animal Health Corporation, Tj Kaiwei, Novavax, Zhuoyue and Aphios, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Oral Vaccine Adjuvants manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Oral Vaccine Adjuvants market. Further, it explains the major drivers and regional dynamics of the global Oral Vaccine Adjuvants market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
SEPPIC
SDA BIO
Croda International
SPI Pharma
Phibro Animal Health Corporation
Tj Kaiwei
Novavax
Zhuoyue
Aphios
GSK
CSL
Brenntag Biosector
SEPPIC
SPI Pharma
Novavax
Avanti Polar Lipids
Aphios
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Oral Vaccine Adjuvants Segment by Type
Veterinary Vaccine Adjuvants
Human Vaccine Adjuvants
Oral Vaccine Adjuvants Segment by Application
Research Application
Commercial Application
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Oral Vaccine Adjuvants market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Oral Vaccine Adjuvants, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Oral Vaccine Adjuvants, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Oral Vaccine Adjuvants, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Oral Vaccine Adjuvants sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Oral Vaccine Adjuvants market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Oral Vaccine Adjuvants sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including SEPPIC, SDA BIO, Croda International, SPI Pharma, Phibro Animal Health Corporation, Tj Kaiwei, Novavax, Zhuoyue and Aphios, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Oral Vaccine Adjuvants in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Oral Vaccine Adjuvants manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oral Vaccine Adjuvants sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Oral Vaccine Adjuvants Product Introduction
1.2 Market by Type
1.2.1 Global Oral Vaccine Adjuvants Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Veterinary Vaccine Adjuvants
1.2.3 Human Vaccine Adjuvants
1.3 Market by Application
1.3.1 Global Oral Vaccine Adjuvants Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Research Application
1.3.3 Commercial Application
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Oral Vaccine Adjuvants Sales Estimates and Forecasts 2017-2028
2.2 Global Oral Vaccine Adjuvants Revenue Estimates and Forecasts 2017-2028
2.3 Global Oral Vaccine Adjuvants Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Oral Vaccine Adjuvants Sales by Region
2.4.1 Global Oral Vaccine Adjuvants Sales by Region (2017-2022)
2.4.2 Global Sales Oral Vaccine Adjuvants by Region (2023-2028)
2.5 Global Oral Vaccine Adjuvants Revenue by Region
2.5.1 Global Oral Vaccine Adjuvants Revenue by Region (2017-2022)
2.5.2 Global Oral Vaccine Adjuvants Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Oral Vaccine Adjuvants Sales by Manufacturers
3.1.1 Global Top Oral Vaccine Adjuvants Manufacturers by Sales (2017-2022)
3.1.2 Global Oral Vaccine Adjuvants Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Oral Vaccine Adjuvants in 2021
3.2 Global Oral Vaccine Adjuvants Revenue by Manufacturers
3.2.1 Global Oral Vaccine Adjuvants Revenue by Manufacturers (2017-2022)
3.2.2 Global Oral Vaccine Adjuvants Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Oral Vaccine Adjuvants Revenue in 2021
3.3 Global Oral Vaccine Adjuvants Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Oral Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Oral Vaccine Adjuvants Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Oral Vaccine Adjuvants Sales by Type
4.1.1 Global Oral Vaccine Adjuvants Historical Sales by Type (2017-2022)
4.1.2 Global Oral Vaccine Adjuvants Forecasted Sales by Type (2023-2028)
4.1.3 Global Oral Vaccine Adjuvants Sales Market Share by Type (2017-2028)
4.2 Global Oral Vaccine Adjuvants Revenue by Type
4.2.1 Global Oral Vaccine Adjuvants Historical Revenue by Type (2017-2022)
4.2.2 Global Oral Vaccine Adjuvants Forecasted Revenue by Type (2023-2028)
4.2.3 Global Oral Vaccine Adjuvants Revenue Market Share by Type (2017-2028)
4.3 Global Oral Vaccine Adjuvants Price by Type
4.3.1 Global Oral Vaccine Adjuvants Price by Type (2017-2022)
4.3.2 Global Oral Vaccine Adjuvants Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Oral Vaccine Adjuvants Sales by Application
5.1.1 Global Oral Vaccine Adjuvants Historical Sales by Application (2017-2022)
5.1.2 Global Oral Vaccine Adjuvants Forecasted Sales by Application (2023-2028)
5.1.3 Global Oral Vaccine Adjuvants Sales Market Share by Application (2017-2028)
5.2 Global Oral Vaccine Adjuvants Revenue by Application
5.2.1 Global Oral Vaccine Adjuvants Historical Revenue by Application (2017-2022)
5.2.2 Global Oral Vaccine Adjuvants Forecasted Revenue by Application (2023-2028)
5.2.3 Global Oral Vaccine Adjuvants Revenue Market Share by Application (2017-2028)
5.3 Global Oral Vaccine Adjuvants Price by Application
5.3.1 Global Oral Vaccine Adjuvants Price by Application (2017-2022)
5.3.2 Global Oral Vaccine Adjuvants Price Forecast by Application (2023-2028)
6 North America
6.1 North America Oral Vaccine Adjuvants Market Size by Type
6.1.1 North America Oral Vaccine Adjuvants Sales by Type (2017-2028)
6.1.2 North America Oral Vaccine Adjuvants Revenue by Type (2017-2028)
6.2 North America Oral Vaccine Adjuvants Market Size by Application
6.2.1 North America Oral Vaccine Adjuvants Sales by Application (2017-2028)
6.2.2 North America Oral Vaccine Adjuvants Revenue by Application (2017-2028)
6.3 North America Oral Vaccine Adjuvants Market Size by Country
6.3.1 North America Oral Vaccine Adjuvants Sales by Country (2017-2028)
6.3.2 North America Oral Vaccine Adjuvants Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Oral Vaccine Adjuvants Market Size by Type
7.1.1 Europe Oral Vaccine Adjuvants Sales by Type (2017-2028)
7.1.2 Europe Oral Vaccine Adjuvants Revenue by Type (2017-2028)
7.2 Europe Oral Vaccine Adjuvants Market Size by Application
7.2.1 Europe Oral Vaccine Adjuvants Sales by Application (2017-2028)
7.2.2 Europe Oral Vaccine Adjuvants Revenue by Application (2017-2028)
7.3 Europe Oral Vaccine Adjuvants Market Size by Country
7.3.1 Europe Oral Vaccine Adjuvants Sales by Country (2017-2028)
7.3.2 Europe Oral Vaccine Adjuvants Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Oral Vaccine Adjuvants Market Size by Type
8.1.1 Asia Pacific Oral Vaccine Adjuvants Sales by Type (2017-2028)
8.1.2 Asia Pacific Oral Vaccine Adjuvants Revenue by Type (2017-2028)
8.2 Asia Pacific Oral Vaccine Adjuvants Market Size by Application
8.2.1 Asia Pacific Oral Vaccine Adjuvants Sales by Application (2017-2028)
8.2.2 Asia Pacific Oral Vaccine Adjuvants Revenue by Application (2017-2028)
8.3 Asia Pacific Oral Vaccine Adjuvants Market Size by Region
8.3.1 Asia Pacific Oral Vaccine Adjuvants Sales by Region (2017-2028)
8.3.2 Asia Pacific Oral Vaccine Adjuvants Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Oral Vaccine Adjuvants Market Size by Type
9.1.1 Latin America Oral Vaccine Adjuvants Sales by Type (2017-2028)
9.1.2 Latin America Oral Vaccine Adjuvants Revenue by Type (2017-2028)
9.2 Latin America Oral Vaccine Adjuvants Market Size by Application
9.2.1 Latin America Oral Vaccine Adjuvants Sales by Application (2017-2028)
9.2.2 Latin America Oral Vaccine Adjuvants Revenue by Application (2017-2028)
9.3 Latin America Oral Vaccine Adjuvants Market Size by Country
9.3.1 Latin America Oral Vaccine Adjuvants Sales by Country (2017-2028)
9.3.2 Latin America Oral Vaccine Adjuvants Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Oral Vaccine Adjuvants Market Size by Type
10.1.1 Middle East and Africa Oral Vaccine Adjuvants Sales by Type (2017-2028)
10.1.2 Middle East and Africa Oral Vaccine Adjuvants Revenue by Type (2017-2028)
10.2 Middle East and Africa Oral Vaccine Adjuvants Market Size by Application
10.2.1 Middle East and Africa Oral Vaccine Adjuvants Sales by Application (2017-2028)
10.2.2 Middle East and Africa Oral Vaccine Adjuvants Revenue by Application (2017-2028)
10.3 Middle East and Africa Oral Vaccine Adjuvants Market Size by Country
10.3.1 Middle East and Africa Oral Vaccine Adjuvants Sales by Country (2017-2028)
10.3.2 Middle East and Africa Oral Vaccine Adjuvants Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 SEPPIC
11.1.1 SEPPIC Corporation Information
11.1.2 SEPPIC Overview
11.1.3 SEPPIC Oral Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 SEPPIC Oral Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 SEPPIC Recent Developments
11.2 SDA BIO
11.2.1 SDA BIO Corporation Information
11.2.2 SDA BIO Overview
11.2.3 SDA BIO Oral Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 SDA BIO Oral Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 SDA BIO Recent Developments
11.3 Croda International
11.3.1 Croda International Corporation Information
11.3.2 Croda International Overview
11.3.3 Croda International Oral Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Croda International Oral Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Croda International Recent Developments
11.4 SPI Pharma
11.4.1 SPI Pharma Corporation Information
11.4.2 SPI Pharma Overview
11.4.3 SPI Pharma Oral Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 SPI Pharma Oral Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 SPI Pharma Recent Developments
11.5 Phibro Animal Health Corporation
11.5.1 Phibro Animal Health Corporation Corporation Information
11.5.2 Phibro Animal Health Corporation Overview
11.5.3 Phibro Animal Health Corporation Oral Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Phibro Animal Health Corporation Oral Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Phibro Animal Health Corporation Recent Developments
11.6 Tj Kaiwei
11.6.1 Tj Kaiwei Corporation Information
11.6.2 Tj Kaiwei Overview
11.6.3 Tj Kaiwei Oral Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Tj Kaiwei Oral Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Tj Kaiwei Recent Developments
11.7 Novavax
11.7.1 Novavax Corporation Information
11.7.2 Novavax Overview
11.7.3 Novavax Oral Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Novavax Oral Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Novavax Recent Developments
11.8 Zhuoyue
11.8.1 Zhuoyue Corporation Information
11.8.2 Zhuoyue Overview
11.8.3 Zhuoyue Oral Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Zhuoyue Oral Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Zhuoyue Recent Developments
11.9 Aphios
11.9.1 Aphios Corporation Information
11.9.2 Aphios Overview
11.9.3 Aphios Oral Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Aphios Oral Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Aphios Recent Developments
11.10 GSK
11.10.1 GSK Corporation Information
11.10.2 GSK Overview
11.10.3 GSK Oral Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 GSK Oral Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 GSK Recent Developments
11.11 CSL
11.11.1 CSL Corporation Information
11.11.2 CSL Overview
11.11.3 CSL Oral Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 CSL Oral Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 CSL Recent Developments
11.12 Brenntag Biosector
11.12.1 Brenntag Biosector Corporation Information
11.12.2 Brenntag Biosector Overview
11.12.3 Brenntag Biosector Oral Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Brenntag Biosector Oral Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Brenntag Biosector Recent Developments
11.13 SEPPIC
11.13.1 SEPPIC Corporation Information
11.13.2 SEPPIC Overview
11.13.3 SEPPIC Oral Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 SEPPIC Oral Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 SEPPIC Recent Developments
11.14 SPI Pharma
11.14.1 SPI Pharma Corporation Information
11.14.2 SPI Pharma Overview
11.14.3 SPI Pharma Oral Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 SPI Pharma Oral Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 SPI Pharma Recent Developments
11.15 Novavax
11.15.1 Novavax Corporation Information
11.15.2 Novavax Overview
11.15.3 Novavax Oral Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Novavax Oral Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Novavax Recent Developments
11.16 Avanti Polar Lipids
11.16.1 Avanti Polar Lipids Corporation Information
11.16.2 Avanti Polar Lipids Overview
11.16.3 Avanti Polar Lipids Oral Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Avanti Polar Lipids Oral Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Avanti Polar Lipids Recent Developments
11.17 Aphios
11.17.1 Aphios Corporation Information
11.17.2 Aphios Overview
11.17.3 Aphios Oral Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Aphios Oral Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Aphios Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Oral Vaccine Adjuvants Industry Chain Analysis
12.2 Oral Vaccine Adjuvants Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Oral Vaccine Adjuvants Production Mode & Process
12.4 Oral Vaccine Adjuvants Sales and Marketing
12.4.1 Oral Vaccine Adjuvants Sales Channels
12.4.2 Oral Vaccine Adjuvants Distributors
12.5 Oral Vaccine Adjuvants Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Oral Vaccine Adjuvants Industry Trends
13.2 Oral Vaccine Adjuvants Market Drivers
13.3 Oral Vaccine Adjuvants Market Challenges
13.4 Oral Vaccine Adjuvants Market Restraints
14 Key Findings in The Global Oral Vaccine Adjuvants Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer